Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
24.80
-0.15 (-0.60%)
At close: Apr 28, 2026, 4:00 PM EDT
24.62
-0.18 (-0.73%)
Pre-market: Apr 29, 2026, 4:19 AM EDT
Arcus Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 3,116 | 2,948 | 1,363 | 1,430 | 1,497 | 2,843 | |
| Market Cap Growth | 259.85% | 116.38% | -4.70% | -4.52% | -47.33% | 68.68% | |
| Enterprise Value | 2,325 | 2,239 | 351 | 623 | 568 | 2,367 | |
| Last Close Price | 24.80 | 23.83 | 14.89 | 19.10 | 20.68 | 40.47 | |
| PE Ratio | - | - | - | - | - | 53.64 | |
| PS Ratio | 12.61 | 11.94 | 5.28 | 12.22 | 13.37 | 7.42 | |
| PB Ratio | 4.92 | 4.67 | 2.81 | 3.10 | 2.28 | 3.38 | |
| P/TBV Ratio | 4.94 | 4.67 | 2.81 | 3.10 | 2.28 | 3.38 | |
| P/FCF Ratio | - | - | - | - | 3.47 | - | |
| P/OCF Ratio | - | - | - | - | 3.42 | - | |
| EV/Sales Ratio | 9.41 | 9.07 | 1.36 | 5.32 | 5.07 | 6.18 | |
| EV/EBITDA Ratio | - | - | - | - | - | 40.82 | |
| EV/EBIT Ratio | - | - | - | - | - | 43.84 | |
| EV/FCF Ratio | - | - | - | - | 1.31 | - | |
| Debt / Equity Ratio | 0.35 | 0.35 | 0.37 | 0.30 | 0.18 | 0.14 | |
| Debt / EBITDA Ratio | - | - | - | - | - | 1.80 | |
| Debt / FCF Ratio | - | - | - | - | 0.28 | - | |
| Net Debt / Equity Ratio | -1.25 | -1.25 | -1.67 | -1.57 | -1.55 | -0.67 | |
| Net Debt / EBITDA Ratio | 2.10 | 2.10 | 2.71 | 2.19 | 3.72 | -9.72 | |
| Net Debt / FCF Ratio | 1.63 | 1.63 | 4.61 | 2.20 | -2.36 | 2.00 | |
| Asset Turnover | 0.22 | 0.22 | 0.23 | 0.10 | 0.08 | 0.32 | |
| Quick Ratio | 4.32 | 4.32 | 4.44 | 4.35 | 5.45 | 7.51 | |
| Current Ratio | 4.36 | 4.36 | 4.50 | 4.52 | 5.53 | 7.60 | |
| Return on Equity (ROE) | -63.26% | -63.26% | -59.77% | -54.87% | -35.62% | 7.89% | |
| Return on Assets (ROA) | -21.08% | -21.08% | -17.26% | -17.42% | -11.92% | 2.85% | |
| Return on Invested Capital (ROIC) | - | - | - | - | -245.61% | 41.81% | |
| Return on Capital Employed (ROCE) | -42.50% | -42.50% | -33.50% | -37.30% | -24.30% | 3.80% | |
| Earnings Yield | -11.33% | -11.97% | -20.77% | -21.47% | -17.83% | 1.86% | |
| FCF Yield | -15.53% | -16.41% | -12.92% | -23.08% | 28.85% | -9.92% | |
| Buyback Yield / Dilution | -19.20% | -19.20% | -21.76% | -2.78% | 2.70% | -35.04% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.